Zobrazeno 1 - 9
of 9
pro vyhledávání: '"R. L. Desjarlais"'
Autor:
J. Briand, David G. Tew, W.W. Smith, I. E. James, L. Lee-Rykaczewski, D. Zymbryki, Sherin S. Abdel-Meguid, Dennis S. Yamashita, Michael S. McQueney, Thaddeus A. Tomaszek, H.-J. Oh, Robert W. Marquis, S. A. Carr, S. M. Halbert, Scott K. Thompson, T. J. Carr, R. L. Desjarlais, Mary J. Bossard, C. A. Janson, M. A. LevyJr., Daniel F. Veber, Karla J. D'Alessio, John G. Gleason, Ru Yu, B. Zhao
Publikováno v:
Peptide Science — Present and Future ISBN: 9780792352716
D.F. VEBER, R.W. MARQUIS, Y. RU, D.S. YAMASHITA, H.-J. OH, S.K. THOMPSON, S.M. HALBERT, T.J. CARR, J.G. GLEASON, T.A. TOMASZEK, JR. M.A. LEVY, M. BOSSARD, D.G. TEW, I.E. JAMES, J. BRIAND, S.A. CARR, D. ZYMBRYKI, L. LEE-RYKACZEWSKI, R.L. DESJARLAIS, M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f4f8585b3d843c232031d7ef5458207
https://doi.org/10.1007/0-306-46864-6_211
https://doi.org/10.1007/0-306-46864-6_211
Autor:
S S, Abdel-Meguid, B W, Metcalf, T J, Carr, P, Demarsh, R L, DesJarlais, S, Fisher, D W, Green, L, Ivanoff, D M, Lambert, K H, Murthy
Publikováno v:
Biochemistry. 33(39)
(2R,4S,5S,1'S)-2-Phenylmethyl-4-hydroxy-5-(tert-butoxycarbonyl) amino-6-phenylhexanoyl-N-(1'-imidazo-2-yl)-2'-methylpropanamide (compound 2) is a tripeptide analogue inhibitor of HIV-1 protease in which a C-terminal imidazole substituent constitutes
Autor:
S K, Thompson, K H, Murthy, B, Zhao, E, Winborne, D W, Green, S M, Fisher, R L, DesJarlais, T A, Tomaszek, T D, Meek, J G, Gleason
Publikováno v:
Journal of medicinal chemistry. 37(19)
The rational design and synthesis of a highly potent inhibitor of HIV-1 protease have been accomplished. The inhibitor, SB 206343, is based on a model derived from the structure of the MVT-101/HIV-1 protease complex and contains a 4(5)-acylimidazole
Autor:
S S, Abdel-Meguid, B, Zhao, K H, Murthy, E, Winborne, J K, Choi, R L, DesJarlais, M D, Minnich, J S, Culp, C, Debouck, T A, Tomaszek
Publikováno v:
Biochemistry. 32(31)
The human immunodeficiency virus type 1 (HIV-1) protease is a potential target of acquired immune deficiency syndrome (AIDS) therapy. A highly potent, perfectly symmetrical phosphinate inhibitor of this enzyme, SB204144, has been synthesized. It is a
Autor:
G L Seibel, R. L. Desjarlais, Juan C. Alvarez, Paul S. Furth, Lilia M. Babé, P R Ortiz de Montellano, D. L. Decamp, Charles S. Craik, Irwin D. Kuntz
By using a structure-based computer-assisted search, we have found a butyrophenone derivative that is a selective inhibitor of the human immunodeficiency virus 1 (HIV-1) protease. The computer program creates a negative image of the active site cavit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b74a4c7f7a57c1c9b75e6e85fe80488
https://europepmc.org/articles/PMC54593/
https://europepmc.org/articles/PMC54593/
Publikováno v:
Anti-cancer drug design. 5(3)
Using a general shape-search docking algorithm, potential DNA minor groove binding compounds were selected from a subset from the Cambridge Crystallographic Database consisting of almost 10,000 molecules. The crystal structure of the DNA dodecamer as
Publikováno v:
Journal of Medicinal Chemistry. 31:722-729
Finding novel leads from which to design drug molecules has traditionally been a matter of screening and serendipity. We present a method for finding a wide assortment of chemical structures that are complementary to the shape of a macromoleculer rec
Publikováno v:
Journal of medicinal chemistry. 29(11)
We present a method to explore the interaction of flexible ligands with receptors of known geometry on the basis of molecular shape. This method is an extension of that described by Kuntz et al. (J. Mol. Biol. 1982, 161, 269). The shape of a binding
Publikováno v:
ChemInform. 18
We present a method to explore the interaction of flexible ligands with receptors of known geometry on the basis of molecular shape. This method is an extension of that described by Kuntz et al. (J. Mol. Biol. 1982, 161, 269). The shape of a binding